mitomycin has been researched along with methoxsalen in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (37.50) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Averbeck, D; Diatloff-Zito, C; Moustacchi, E; Papadopoulo, D | 1 |
| Arwert, F; Eriksson, AW; Kortbeek, HT; Poll, EH | 1 |
| Linnainmaa, K; Wolff, S | 1 |
| Alapetite, C; Averbeck, D; Baroche, C; Barret, JM; Levy, E; Moustacchi, E; Salles, B | 1 |
| Kanemichi, Y; Ohmae, S; Ohta, T; Tokishita , S; Yamagata, H; Yamaya, K | 1 |
1 review(s) available for mitomycin and methoxsalen
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
7 other study(ies) available for mitomycin and methoxsalen
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Abnormal response to DNA crosslinking agents of Fanconi anemia fibroblasts can be corrected by transfection with normal human DNA.
Topics: Anemia, Aplastic; Base Sequence; Cell Line; Cross-Linking Reagents; DNA; Drug Resistance; Fanconi Anemia; Fibroblasts; HLA Antigens; Humans; Methoxsalen; Mitomycin; Mitomycins; Transfection | 1986 |
Fanconi anaemia cells are not uniformly deficient in unhooking of DNA interstrand crosslinks, induced by mitomycin C or 8-methoxypsoralen plus UVA.
Topics: Cell Line; Cross-Linking Reagents; DNA Repair; Fanconi Anemia; Furocoumarins; Humans; Methoxsalen; Mitomycin; Mitomycins; Phenotype; Trioxsalen | 1984 |
Sister chromatid exchange induced by short-lived monoadducts produced by the bifunctional agents mitomycin C and 8-methoxypsoralen.
Topics: Animals; Cells, Cultured; Chromosomes; Cricetinae; Cricetulus; Crossing Over, Genetic; DNA; Female; Furocoumarins; Methoxsalen; Mitomycin; Mitomycins; Ovary; Sister Chromatid Exchange; Structure-Activity Relationship; Ultraviolet Rays | 1982 |
Activated ras oncogene and specifically acquired resistance to cisplatin in human mammary epithelial cells: induction of DNA cross-links and their repair.
Topics: Breast; Cell Division; Cell Line; Cell Line, Transformed; Cell Survival; Cell Transformation, Neoplastic; Cisplatin; DNA; DNA Damage; DNA Repair; Doxorubicin; Drug Resistance; Epithelial Cells; Epithelium; Female; Gene Expression Regulation; Genes, ras; Humans; Methoxsalen; Mitomycin; Sensitivity and Specificity | 1994 |
Characterization of the mutational specificity of DNA cross-linking mutagens by the Lac+ reversion assay with Escherichia coli.
Topics: Antineoplastic Agents; Carboplatin; Cisplatin; Cross-Linking Reagents; Dose-Response Relationship, Drug; Escherichia coli; Ficusin; Lac Operon; Light; Methoxsalen; Mitomycin; Mutagenicity Tests; Mutagens; Mutation; Photosensitizing Agents; Point Mutation | 2001 |